Charleston, SC -- (SBWIRE) -- 08/17/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: Gazprom OAO (ADR) (OTCMKTS:OGZPY), Advanced Cell Technology, Inc. (OTCBB:ACTC), Invivo Therapeutics Holdings Corp (OTCBB:NVIV), Tranzbyte Corp (OTCMKTS:ERBB)
Gazprom OAO (ADR) (OTCMKTS:OGZPY) remained a bear for the day as it reported the loss of -0.67% and closed at $7.89 after gaining total volume of 434,893 shares. Its introductory price for the day was $7.84. So far, the company’s stock is up +1.68% in the three months period. In the last 6 months of trade it reported a decline of -10.85%.
OAO Gazprom, together with its subsidiaries, engages in the exploration and production of oil and gas. It produces crude oil and gas condensate. The company also engages in the storage, transportation, and sale of gas; and processing of oil, gas condensate, and other hydrocarbons, as well as sale of refined products. In addition, it is involved in the generation and sale of electric and heat energy.
Has OGZPY Found The Bottom And Ready To Gain Momentum? Find Out Here
Advanced Cell Technology, Inc. (OTCBB:ACTC) reported the decline of -1.14% and closed at $ 0.0692 with the total traded volume of 6.47 million shares. The stock's opening price was $ 0.07. The company has a total market capitalization of $ 177.43 million.
The 52-week price range of the stock remained $0.05 - $0.10, while during last trade its minimum price was $0.07 and it gained its highest price of $0.07. Company's last 5 days shows down turn with a decline of -10.00%. Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine.
Why Should Investors Buy ACTC After the Recent Fall? Just Go Here and Find Out
Invivo Therapeutics Holdings Corp (OTCBB:NVIV) ended its day with the gaining stream with the rise of +0.43% and closed at the price of $4.20 after opening at $4.15. Stock traded during its last trading session with the total volume of 158,762 shares, as compared to its average volume of 561,786 shares.
During the previous session, the company’s minimum price was $4.05, while it touched its highest price for the day at $4.20. NVIV’s beta value stands at 9.81 points. Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions
For How Long NVIV’s Gloss will Attract Investors? Find out via this report
Tranzbyte Corp (OTCMKTS:ERBB) reported the drop of -4.35%, to close at $0.0022, with the overall traded volume of 121.49 million shares.
So far, in the past three months, the stock is down -54.17%. The 52-week range for the stock is $0.0008 and $0.193 and during the previous trading session the stock touched its highest price at $0.0028. Its introductory price for the day was $0.0024. Tranzbyte Corporation operates medical marijuana retail dispensaries under the Altitude Organic Medicine brand name in California, Colorado, and Arizona.
Will ERBB Get Buyers Even After The Recent Rally? Find Out Here
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)